Cutler Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,200
| Closed | -$18K | – | 4059 |
|
|
2022
Q4 | $18K | Buy |
8,200
+3,200
| +64% | +$131K | ﹤0.01% | 2280 |
|
|
2022
Q3 | $97K | Sell |
5,000
-8,500
| -63% | -$350K | 0.01% | 1407 |
|
|
2022
Q2 | $287K | Buy |
13,500
+1,400
| +12% | +$74.9K | 0.02% | 790 |
|
|
2022
Q1 | $113K | Sell |
12,100
-6,500
| -35% | -$475K | 0.01% | 1602 |
|
|
2021
Q4 | $261K | Buy |
18,600
+14,900
| +403% | +$1.31M | 0.01% | 1122 |
|
|
2021
Q3 | $12K | Buy |
3,700
+1,000
| +37% | +$106K | ﹤0.01% | 3758 |
|
|
2021
Q2 | $5K | Hold |
2,700
| – | – | ﹤0.01% | 4420 |
|
|
2021
Q1 | $9K | Sell |
2,700
-8,600
| -76% | -$1.18M | ﹤0.01% | 3874 |
|
|
2020
Q4 | $11K | Buy |
11,300
+3,300
| +41% | +$399K | ﹤0.01% | 3117 |
|
|
2020
Q3 | $85K | Sell |
8,000
-7,700
| -49% | -$665K | 0.01% | 1425 |
|
|
2020
Q2 | $147K | Buy |
15,700
+6,500
| +71% | +$519K | 0.01% | 1048 |
|
|
2020
Q1 | $302K | Sell |
9,200
-15,800
| -63% | -$1.28M | 0.02% | 753 |
|
|
2019
Q4 | $229K | Sell |
25,000
-2,800
| -10% | -$246K | 0.01% | 761 |
|
|
2019
Q3 | $197K | Buy |
27,800
+11,400
| +70% | +$1.3M | 0.02% | 710 |
|
|
2019
Q2 | $8K | Buy |
16,400
+9,300
| +131% | +$937K | ﹤0.01% | 2815 |
|
|
2019
Q1 | $8K | Sell |
7,100
-57,000
| -89% | -$4.85M | ﹤0.01% | 2634 |
|
|
2018
Q4 | $76K | Buy |
64,100
+4,300
| +7% | +$295K | 0.01% | 1220 |
|
|
2018
Q3 | $19K | Buy |
59,800
+3,100
| +5% | +$202K | ﹤0.01% | 2267 |
|
|
2018
Q2 | $31K | Sell |
56,700
-4,500
| -7% | -$242K | ﹤0.01% | 1903 |
|
|
2018
Q1 | $149K | Buy |
61,200
+2,000
| +3% | +$97.6K | 0.01% | 960 |
|
|
2017
Q4 | $52K | Buy |
59,200
+17,600
| +42% | +$940K | ﹤0.01% | 1827 |
|
|
2017
Q3 | $53K | Sell |
41,600
-12,200
| -23% | -$491K | ﹤0.01% | 2186 |
|
|
2017
Q2 | $46K | Sell |
53,800
-35,100
| -39% | -$1.08M | ﹤0.01% | 2574 |
|
|
2017
Q1 | $52K | Buy |
88,900
+36,100
| +68% | +$715K | ﹤0.01% | 2374 |
|
|
2016
Q4 | $109K | Buy |
52,800
+24,800
| +89% | +$400K | ﹤0.01% | 1835 |
|
|
2016
Q3 | $23K | Buy |
28,000
+7,000
| +33% | +$123K | ﹤0.01% | 3276 |
|
|
2016
Q2 | $15K | Buy |
21,000
+10,700
| +104% | +$80.6K | ﹤0.01% | 3661 |
|
|
2016
Q1 | $79K | Sell |
10,300
-600
| -6% | -$3.84K | 0.01% | 1843 |
|
|
2015
Q4 | $169K | Buy |
+10,900
| New | +$101K | 0.01% | 1326 |
|
Other funds holding EXAS
AIM
Cutler Group's EXAS Position: Q3 2023 in Review
Cutler Group sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 203 shares — an estimated $19K sold.
Cutler Group first reported a position in EXAS in Q4 2015 and held it in 26 quarters. The position peaked at $1.01M in Q4 2020. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.
- Cutler Group reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
- Cutler Group sold 203 Exact Sciences shares in Q3 2023, an estimated $19K.
- Cutler Group first reported a position in Exact Sciences in Q4 2015 and held it in 26 quarters.
- Cutler Group's Exact Sciences position peaked at $1.01M in Q4 2020.
- 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.
Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.